As the clinical leader of the largest operational department in a skilled nursing facility, the director of nursing services (DNS), in tandem with the administrator, plays a key role in financial oversight. Ancillary charges are rooted in nursing-driven systems, so reviewing financials and billing is a shared responsibility. This article offers practical guidance to help DNS leaders approach ancillary billing reviews with greater understanding and confidence.
Why Billing Review Involves the DNS
For many DNS leaders, billing can feel removed from daily practice. But ancillary services represent clinical decisions and care needs. They reflect why a resident required intravenous (IV) antibiotics, why oxygen therapy continued, why specialty wound treatment was initiated, or why an injectable medication was ordered. Each of these decisions must be clinically appropriate, clearly documented, and financially defensible.
Under the Patient-Driven Payment Model (PDPM), certain ancillary services significantly influence Medicare Part A reimbursement. Medicare administrative contractors and other payers are increasingly scrutinizing high-cost services. Payment integrity reviews are now routine rather than exceptional.
The DNS stands at the center of this intersection. Clinical systems generate ancillary charges, and if documentation, physician intent, and billing fail to align, the facility faces financial exposure and regulatory risk.
Financial Risk and Regulatory Risk Travel Together
Of course regulations are tied to billing, and compliance is inseparable from revenue and expenses in long-term care.
Although no regulation addresses ancillary billing alone, Appendix PP clarifies that every billed service must meet the same regulatory standards as any other aspect of resident care. For example, per F658, services must align with professional standards of practice. F685 requires residents to receive the care and services they need to attain or maintain their highest practicable well-being. F842 stipulates that the medical record must accurately reflect the care provided, and F755 holds the facility accountable for the appropriate indication, monitoring, and oversight of medications. When IV therapy or respiratory services are required, infection prevention requirements under F880 also apply.
If documentation does not support medical necessity, a claims denial may follow. When services appear excessive or poorly justified, survey scrutiny often follows the same pattern.
Consider what happens when IV antibiotics continue beyond the expected treatment window without documented reassessment. A payer may deny the claim due to lack of medical necessity. A surveyor may question whether professional standards were followed. In both cases, the same documentation gap drives both outcomes.
Similarly, if documentation does not clearly reflect what was actually administered, the facility risks billing for a service the resident did not receive or submitting duplicate charges for overlapping services. Whether caused by communication breakdown, order entry error, or vendor misalignment, these discrepancies create serious compliance exposure. Billing for services not rendered or billing twice for the same service is more than a clerical error. It can trigger repayment, civil monetary penalties, or allegations of false claims.
In each of these examples, the root cause is the same. When clinical documentation, physician orders, and billing processes do not match up, both regulatory standing and financial integrity are compromised. The DNS must therefore approach ancillary billing review as a clinical integrity process with direct financial implications. Every service should tell a coherent story from physician order to daily note to final bill.
Where Financial Leakage Commonly Occurs
Ancillary financial vulnerability rarely stems from intentional misuse. More often, it results from process drift, unclear communication, or routine continuation without reassessment.
Pharmacy services clearly illustrate this vulnerability. High-cost injectables, prolonged IV antibiotics, anticoagulants requiring close monitoring, and psychotropic medication adjustments all carry both clinical complexity and financial implications. When indications are not clearly documented, monitoring parameters are absent from nursing notes, or stop dates are undefined, services may continue longer than clinically necessary. Those scenarios increase pharmacy expenses and create exposure if medical necessity is challenged.
Respiratory and IV services pose similar challenges. Oxygen initiated during an acute change in condition may continue without formal reassessment. Nebulizer treatments may not be evaluated because no clear discontinuation plan was documented. IV fluids may extend beyond the initial order because no one clarified duration.
In each case, the original clinical decision may have been appropriate. The risk arises when continuation is not actively justified. These services often contribute to higher reimbursement categories under PDPM and can influence managed care negotiations based on acuity mix. The financial driver is clear. Higher perceived acuity can mean higher payment. But if documentation does not show ongoing skilled need, the facility risks denial, recoupment, and potential allegations of billing for services not medically necessary.
Laboratory testing also warrants scrutiny. Standing panels are common in long-term care, and vendor agreements sometimes bundle pricing that obscures per-test cost. The financial incentive may be convenience or standing protocol rather than individualized need. Repeating broad panels without clinical triggers increases vendor expense and can erode margin, particularly under capitated or per diem managed care contracts where laboratory costs are not separately reimbursed. If abnormal results lack documented provider follow-up, the facility absorbs not only the testing cost but also potential liability exposure and the risk of the resident needing to be rehospitalized.
Wound care often carries some of the highest ancillary costs in the long-term care. Advanced modalities such as negative pressure wound therapy and specialty dressings may increase reimbursement under Medicare Part A because of associated clinical complexity. That financial enhancement can unintentionally delay critical reassessment. Supplies are expensive, vendor contracts may incentivize using particular products, and treatment continuation can become routine.
When wounds plateau and the modality continues without documented modification or physician involvement, the facility faces both rising supply expense and audit vulnerability. What initially supported appropriate reimbursement can quickly shift into financial leakage and compliance exposure if clinical progression is not evident and well documented.
Moving from Reactive Review to Proactive Oversight
A structured monthly clinical-financial review meeting encourages both accountability and strategic thinking. Instead of addressing denials after they occur, the team examines trends in real time. High-cost residents, services extending beyond expected duration, and unusual charge patterns can be examined before they become external findings. This process is not about limiting care. It is about validating care.
Targeted chart-to-bill comparisons add depth to the review. When the DNS selects several high-cost cases each month and compares the physician order, clinical documentation, and billed services side by side, gaps become apparent. If documentation does not clearly support the service billed, the facility can educate staff and strengthen systems before payment is jeopardized.
The findings from these meetings should also feed directly into the facility’s quality assurance and performance improvement (QAPI) program. Repeated documentation inconsistencies, prolonged service durations without reassessment, or frequent denials signal system-level issues. QAPI provides the structure needed to address those concerns in a systematic and productive way.
Strengthening Financial Awareness Within Nursing Leadership
Financial literacy is rarely emphasized in nursing education. Yet in today’s environment, the DNS must understand the financial implications of all aspects of clinical practice.
Sharing high-level cost information with nurse managers can shift perspective. When leaders understand the average cost of a prolonged IV antibiotic course, the monthly expense of respiratory supplies, or the financial implications of excessive or improper ordering, documentation takes on new urgency. Clarity in charting becomes part of protecting the facility’s ability to continue offering high-quality care.
This approach should never frame cost control as the primary goal. Resident-centered care remains paramount. However, unnecessary or poorly justified services can strain limited resources. Financial stewardship supports sustainability, ultimately benefiting residents.
Appendix PP emphasizes individualized, necessary, and professionally appropriate care. Financial oversight ensures that services remain aligned with that expectation rather than drifting into routine extension without clinical purpose.
The DNS as Financial-Clinical Integrator
The DNS oversees many clinical systems, and ancillary services intersect most, if not all, of those. When ancillary billing review becomes part of regular practice, outcomes improve across the organization. Documentation strengthens because expectations are clear. Costs stabilize because services billed are reassessed routinely. Denials decrease because records support medical necessity. Appeals succeed more often because the clinical story is coherent. Cash flow becomes more predictable. Survey readiness improves because services align with professional standards. Most importantly, residents receive needed services that are goal directed and evaluated actively.
Financial stability does not compete with quality care. In long-term care, it sustains it. Ancillary billing review is not a task allocated to the business office or only conducted during audit season. It is a strategic leadership function that protects margin, compliance, and resident outcomes simultaneously. In today’s reimbursement environment, the DNS plays a crucial role in that process. For more help, see the AAPACN’s Ancillary Billing Review Checklist.
This AAPACN resource is copyright protected. AAPACN individual members may download or print one copy for use within their facility only. AAPACN facility organizational members have unlimited use only within facilities included in their organizational membership. Violation of AAPACN copyright may result in membership termination and loss of all AAPACN certification credentials. Learn more.